U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. FDA CBER Office of Therapeutic Products (OTP) Advanced Manufacturing and Analytical Technologies (AMAT) for Regenerative Medicine Therapies (RMT) Workshop - 03/14/2023
  1. FDA Meetings, Conferences and Workshops

Virtual | Virtual

Event Title
FDA CBER Office of Therapeutic Products (OTP) Advanced Manufacturing and Analytical Technologies (AMAT) for Regenerative Medicine Therapies (RMT) Workshop
March 14, 2023

Date:
March 14, 2023
Time:
9:00 AM - 4:45 PM ET

Description:

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) will host a virtual workshop for FDA staff and cell and gene therapy stakeholders to obtain specialized knowledge from experts in the field of advanced manufacturing and analytical technologies (AMAT) for regenerative medicine therapies (RMT), discuss innovative manufacturing technologies and alternative testing methods, and share experiences, challenges, and best practices critical for chemistry, manufacturing, and controls (CMC) of cellular and gene therapies and tissue engineered medical products.

This workshop will be comprised of external speakers, presentations, and panel discussions with experts in the AMAT field from academia, government, and industry. 

Keynote speakers include Dr. Krishnendu Roy, Regents Professor, Director, NSF ERC for Cell Manufacturing Technologies and Marcus Center for Cell Manufacturing, Georgia Institute of Technology; and Dr. Jude Samulski, Director, Gene Therapy Center, University of North Carolina.

Topics:

This workshop will include presentations and discussions on the current and future advanced manufacturing processes and analytical technologies used in the manufacturing of cellular therapies, gene therapies and tissue engineered medical products. Topics for discussion include but are not limited to:

  1. Advances in Adeno-Associated Virus (AAV) development and manufacturing. Novel analytical methods for AAV product characterization. 
  2. Tissue engineered medical product manufacturing, including biomaterials and 4D bioprinting.
  3. Advances in iPSC and MSC-extracellular vesicle manufacturing.
  4. Manufacturing scaling technologies, including integration and implementation of artificial intelligence and digital twins to support process modelling and cell therapy manufacturing.

The complete agenda for this workshop can be found here and on the event registration page.

Attendance Details

To register for the workshop and submit questions or comments related to this event, please visit the registration page. Following registration, a link will be delivered containing the Zoom session’s information.

Workshop Materials

Recordings for this workshop are linked below and can also be found on the registration page.

 
Back to Top